ABSTRACT Motivation: Chromosomal copy number changes (aneuploidies) are common in cell populations that undergo multiple cell divisions including yeast strains, cell lines, and tumor cells. Identification of aneuploidies is critical in evolutionary studies, where changes in copy number serve an adaptive purpose, as well as in cancer studies, where amplifications and deletions of chromosomal regions have been identified as a major pathogenetic mechanism. Aneuploidies can be studied on whole-genome level using array CGH (a microarraybased method that measures DNA content), but their presence also affects gene expression.
INTRODUCTION
Chromosomal amplifications, deletions, and rearrangements are thought to play important evolutionary roles in speciation (Fischer et al., 2000) and adaptive mutation in yeast and microbial populations (Hendrickson et al., 2002; Dunham et al., 2002) , and constitute a key mechanism in cancer progression (Cahill et al., 1999; Phillips et al., 2001) . Aneuploidies are especially common in cell populations that undergo multiple cell divisions such as laboratory strains or cell lines, and presence of amplifications or deletions of whole chromosomes or their parts (segmental aneuploidies) can have substantial effects on gene expression (Fritz et al., 2002; Haddad et al., 2002; . Thus, identification of aneuploidies is important in cancer pathogenesis and molecular evolution studies, as well as in every genome-scale gene expression microarray experiment because copy number changes can alter expression profiles and result in spurious correlations of functionally unrelated genes.
Recent developments in microarray technology have enabled genome-wide investigations of copy-number changes through array-based comparative genomic hybridization (array CGH), where differentially labeled sample and reference DNA are hybridized to DNA microarrays (Pinkel et al., 1998; Pollack et al., 1999) . This technology has proven effective in identifying aneuploidies in tumor cells (Gray and Collins, 2000; Phillips et al., 2001; Wilhelm et al., 2002; Linn et al., 2003) , experimental evolution studies (Dunham et al., 2002) , and in yeast strains Pérez-Ortín et al., 2002) . Routine application of array CGH to every strain or tissue used in gene expression studies is unfortunately not feasible. However, several studies have demonstrated that chromosomal abnormalities correlate with spatial biases in gene expression along chromosomes (Pollack et al., 2002; Fritz et al., 2002; Haddad et al., 2002; Linn et al., 2003; Mukasa et al., 2002; Phillips et al., 2001; Virtaneva et al., 2001) . For example, Pollack et al. estimate that 62% of highly amplified genes in 37 breast cancer tumors demonstrate moderately or highly elevated expression. Thus, aneuploidies can be detected in gene expression or array CGH microarray data, and it is necessary to develop analysis methods that can accurately identify chromosomal abnormalities based on either.
Accurate identification of aneuploidies from thousands of array CGH or gene expression measurements requires robust computational methods. Most array CGH data analyses involve heuristics and threshold-based methods (Dunham et al., 2002; Pollack et al., 2002) . Recently, Autio et al. (2003) presented a dynamic-programming-based approach to identifying copy-number changes from array CGH data, which addressed the problem algorithmically for CGH data but lacked significance analysis. Accurate identification of potential copy number changes based on gene expression data is even more challenging because of mRNA expression levels reflect transcriptional regulation as well as DNA copy number. Previous approaches for aneuploidy detection from gene expression data focus only on whole-chromosome or chromosomal-arm copy number changes, and most methods are based on heuristics or dataset-specific thresholds. In the most sophisticated method to date, Crawley et al. (2002) employ a sign test for detecting whole chromosome (or whole arm) expression biases. use a simpler errorweighted mean approach for whole-chromosome aneuploidy detection and a heuristic scanning method that identifies adjacent occurrences of 4 over or under-expressed genes as potential segmental aneuploidies. A visualization-based imbalance detection scheme for identifying biases common in cancer specimens as compared to normal samples is proposed by Kano et al. (2003) . These methods address the problem of whole chromosome or chromosomal arm copy changes, but the issue of robust identification of segmental aneuploidies remains open.
Here we present ChARM, a robust and accurate statistical method for identification of segmental aneuploidies from gene expression or array CGH microarray data. Our technique provides three key improvements over previously suggested approaches. First, nearly all current aneuploidy detection schemes for expression data rely on thresholds for defining significant over-and under-expression levels (some requiring up to a 1.7-1.8 fold change). Recent studies suggest, however, that expression level changes do not always directly reflect copy change proportions, and thresholds determined for one data set often will not generalize to others (Phillips et al., 2001 ). Our method is statistical, and therefore generalizes to different datasets, microarray platforms, and organisms. Second, we focus on the problem of detecting segmental aneuploidy, which is generally more difficult than detecting whole-chromosome aneuploidy for which the methods developed by or Crawley et al. (2002) are effective. Third, our method is general and performs well with both gene expression and array CGH data.
ChARM employs an edge detection filter that identifies potentially aneuploid regions, an EM algorithm that finds maximum likelihood breakpoints based on a local search in these potential regions, and a statistical analysis that determines which predicted aneuploidies correspond to statistically significant biases as opposed to experimental noise. Our scheme can accurately identify known aneuploidies in biological gene expression or array CGH data , and rigorous performance analysis with synthetic data demonstrates that the method is robust to noise and aneuploidy size and thus can generalize to other microarray data sets. Applying ChARM to 300 gene expression profiles of laboratory yeast strains, we identify multiple previously unknown aneuploidies, most of which are supported by current biological knowledge of yeast chromosomal rearrangement mechanisms. Our analysis of breast cancer array CGH and gene expression microarray data identifies both known and novel areas of chromosomal instability and reveals two groups of immune system genes on different chromosomes that are overexpressed and often amplified in a subset of breast tumors. This novel result may, upon experimental verification, contribute to understanding of how cancers escape immune response.
METHODS
ChARM is composed of three sub-systems: an edge detection filter that identifies points on chromosomes where potential aneuploidies start or end, an EM-based edge-placement algorithm that statistically optimizes these start and end locations, and a window significance test that determines whether predicted amplifications and deletions are statistically significant or are artifacts of noise (Figure 1 ). The EM algorithm has a wellknown tendency to find local rather than global maxima, but this three-stage structure is useful in setting initial conditions that ensure meaningful convergence. All three stages assume input in the form of array CGH or gene expression log ratios arranged in the order in which the corresponding genes appear along a single chromosome.
Edge Detection Filter
The edge detection filter estimates locations along the chromosome where abrupt changes in gene expression occur. This is accomplished by a simple cascade of a non-linear median filter, a linear smoothing filter, and a linear differentiator (Figure 2 ). The median filter functions as a high-level smoother, removing outliers, which are common in microarray data, and preserving only sustained changes in the input sequence. Finer smoothing, which is a necessary pre-processing step for the differentiator, is accomplished by a linear averaging filter with a smaller window size. The differentiator effectively computes the derivative over a short window flagging any substantial changes with large peaks. These peaks and the corresponding chromosomal locations serve as the input to the more precise EM algorithm.
Expectation-Maximization Edge-Placement Algorithm
The purpose of the EM edge-placement algorithm is to provide fine adjustments to the edge estimates from the previous filter. To facilitate convergence to statistically optimal gene indices, each edge is surrounded by a "radius of influence" (ROI), which includes an equal-length set of adjacent genes on either side that is allowed to affect the placement at a given iteration. Furthermore, each edge is associated with two distributions, one for each of the two distinct regions (left and right) it is potentially separating. Each iteration of the algorithm consists of two stages: a typical EM clustering stage for learning the maximum likelihood parameters of the two distributions for each ROI (see E-step, M-step 1 below) and an edge-placement stage which adjusts the edge position optimally given the learned parameters (see M-step 2 below). Before each edge adjustment, every pair of adjacent windows 1 is tested for similarity to ensure that the edge between these windows actually separates chromosomal regions of different copy number. The algorithm converges when all edge positions are fixed for several iterations. Each of these steps is described in detail below.
Update membership (E-step)
Soft (fuzzy) memberships are computed for all genes in the radius of influence of an edge and are proportional to the probability of observing the gene given the left and right distributions associated with that edge. Let
represent the log-transformed ratio (array CGH or expression) and location of gene i , Also, let inf r denote the radius of influence. Here, we assume that the set of genes in the ROI lie in two normal distributions, i.e.
( )
. Then, the conditional probability of observing gene i given the distribution
which allows us to compute the posterior probability of
and g n is the number of genes on the chromosome of interest.
Mean and variance computation (M-step 1)
Based on the membership
determined in the E-step, the maximum likelihood mean and variance parameters for the next iteration ( 1 + t ) are computed as follows (Dempster et al., 1976): 1 We refer to the regions between any two adjacent edges or between an edge and a chromosome end as "windows". 2 Note that in our implementation, we use normally distributed i g 's. Empirically, this has demonstrated adequate performance, but this approach can be generalized to other, more accurate models as well.
Edge adjustment (M-step 2)
For edge adjustment, we use the information theoretic notion of surprise (i.e. the amount of information learned from observing a probabilistic event). At each iteration, we restrict the possible edge locations to only the set of indices included in the current ROI. Each placement implies a different clustering of the genes around the edge into the left or right edge distributions. Each gene's placement in the implied cluster is treated as the observation of a random variable whose probability distribution is the gene's posterior probability of being associated with that cluster. 
Then, the "minimum surprise" edge placement is
given by:
where the indices ) r ( inf 1 2 1 + K refer to those genes in the ROI. Upon adjusting the edge placement for each window, the window parameters are updated accordingly (i.e.
).
Window similarity test
The window similarity test is needed at each iteration to ensure that edges about to be adjusted actually separate different windows with distinct chromosomal biases (separate aneuploidy predictions). The difference between left and right windows on either side of an edge must exceed a minimum signal-to-noise threshold or the edge is removed. As noted earlier, a window that extends beyond the ROI includes all genes up to the next edge or chromosome end. We have evaluated several parametric and non-parametric statistical metrics for measuring the difference between two sets of samples including t-test, non-parametric t-tests, rank-sum test, KolmogorovSmirnov test. Empirically, the ratio of the difference in medians between two adjacent windows and the pooled absolute deviation from the median has demonstrated the best performance. Thus, we impose the following criterion on this modified signal-to-noise ratio (SNR) for removing an edge ( thresh SNR is a threshold dependent on the current convergence behavior measured by e δ , the average edge position change (in gene indices) from one iteration to the next. We raise the minimum SNR threshold as the edge positions begin to converge so that adjacent windows must be "more different" to remain separate as edges approach their final estimates.
Window Significance Analysis
Once the EM algorithm obtains precise window positions, the significance analysis scheme determines if each window represents a statistically significant spatial bias in DNA content or expression. We consider three statistical tests for assessing the significance of windows identified by the EM algorithm: a one-sample sign test, a mean permutation test, and a coefficient of variance permutation test, as well as combinations of the mean and sign tests and the variance and sign tests. The sign test is that reported by Crawley et al. (2002) with the modification that the threshold is chosen dynamically for each chromosome to allow for identification of biased regions exhibiting lower degrees of over or under-expression than the 1.7-1.8 fold threshold used by others (Crawley et al., 2002) . Both permutation tests require performing approximately 5,000 random permutations of the genes on the chromosome and comparing the statistic (mean or variance) obtained on the actual arrangement with the most significant statistic for the same window size on each random permutation. We use the Bonferroni method to correct for multiple hypothesis tests on the same chromosome. Our permutation tests are designed specifically for the segmental aneuploidy problem, while other methods such as the sign test or the error-weighted mean approach proposed in are more appropriate for chromosome-wide bias detection.
EVALUATION
To systematically assess ChARM's accuracy and robustness, we evaluate it using a synthetic microarray measurement error model described below. Using this model, we assess which window significance test yields the best performance for aneuploidy detection and thoroughly evaluate the robustness of our scheme. We further evaluate our scheme on biological data (see Application to Biological Data).
Synthetic data model
We generate synthetic two-color microarray data according to the model proposed by Rocke and Durbin (2001) . Under this two-component model, reference ( R y ) and test ( T y ) intensity values are simulated as:
where α is the mean background intensity, µ is the intensity contributed by the quantity of interest, and
This model was originally proposed for gene expression microarrays, but it is also appropriate for array CGH experiments with the modification that R µ and T µ are amounts of reference and test genomic DNA rather than mRNA. The parameters denoted by the subscript "s" are characteristics of the microarray spot and common to both reference and test samples. The mean background intensities (α ) are typically estimated by microarray image analysis software and used to compute estimates of test and reference signal intensities, T x and R x , as follows:
We model the error in this background estimation,α , as an additional normally distributed error term, est ε , so that the pre-log-ratio intensities are generated as: 3 (prior to noise effects). Furthermore, to model expression scenarios realistically, 10% of the genes outside of aneuploidal regions are randomly set to over-or under-expressed with no spatial correlation.
Choice and performance of window significance test
We first address the question of choosing the window significance test for our framework. We consider three window significance tests (sign test, mean test, coefficient of variance test) and evaluate their performance on simulated 50-gene aneuploidies under varying p-value cutoffs (Figure 3 ). Under all conditions tested, the mean and coefficient of variance permutation tests perform overwhelmingly better than the one-sample sign test, which is used by Crawley et al. (2002) and Haddad et al. (2002) . However, when an aneuploidy is located on the end of a chromosome, the mean test, which is generally very specific, can falsely report the region spanning the rest of the chromosome as significant based on the permutations. This shortcoming of the permutationbased approach can be overcome by combination with the simpler sign test. This combined mean permutation and sign test scheme performs best both in terms of specificity and sensitivity, and is thus used in the rest of evaluation experiments. A similar combination of the coefficient of variance test and the sign test is less effective because the variance-based test yields lower sensitivity due to the noisy characteristics of microarray data.
Robustness evaluation
We also examine the performance of ChARM under varying noise conditions. The performance of the method is only minimally affected by additive noise ( ε parameters) (data not shown). The effect of multiplicative error (η ) in test and reference samples is shown in Figure 4 . The sensitivity of the algorithm is robust ( ≥ .9) to noise levels well above the biological range ( Figure 4A , Table 1 ), and the specificity ranges from 1 to .94 for all noise parameters (data not shown). Our method provides accurate edge placement at biologically realistic noise levels (average edge coordinate error < 8%) ( Figure 4B ). Edge coordinate error is defined as To test for bias in our method's performance toward particular aneuploidal segment sizes, we perform a similar noise analysis across a range of typical lengths (results not shown). At moderate biological noise levels (0.1), the algorithm identifies even small segments (< 10 genes) of copy-number change with very high specificity (> .95). Under severe noise conditions the sensitivity of the detection algorithm degrades quite noticeably for very small aneuploidies (much less than 100 genes in length). However, the algorithm is able to detect larger copy number changes (>100 genes) even under high noise conditions ( T η σ 10 times greater than typical biological noise) with relatively high sensitivity. The edge coordinate errors behave similarly, although with less degradation. Both effects are due to the fact that separating signal from noise becomes more difficult as the length of spatial correlation decreases. Therefore our scheme is robust to noise and can accurately identify aneuploidy regions even under high noise conditions.
APPLICATIONS TO BIOLOGICAL DATA
We applied ChARM to the yeast deletion mutants' gene expression data set of Hughes and Marton et al. (2000) and to gene expression and array CGH data for breast cancer patients from (Pollack et al., 2002) . The results, presented below, demonstrate that our method can be successfully applied to both gene expression and array CGH biological data for different organisms. We outline known amplifications and deletions that ChARM identifies and present some novel aneuploidies we find as well.
Segmental aneuploidies in S. cerevisiae deletion mutants
We applied our method to the compendium of expression profiles of 300 S. cerevisiae deletion mutants and drug-treated strains developed and previously analyzed for aneuploidies by . The analysis by Hughes et al. emphasizes whole-chromosome copy number changes, and they identify based on gene expression data and confirm by array CGH only two segmental aneuploidies 4 . Our method identifies these confirmed segmental aneuploidies (rpl20a∆/rpl20a∆ and rad27∆/rad27∆ strains) with high confidence (rad27∆/rad27∆: sign test p-value of 10 -5 , mean permutation test p-value of <10 -4 ; rpl20a∆/rpl20a∆: sign test pvalue of 10 -7 , mean permutation test p-value of <10 -4 ). In addition to confirming the segmental aneuploidies identified by Hughes et al., we identify a number of previously unknown potential aneuploidal regions 5 , the top 100 (sign test p-values of < 10 -3 and mean permutation test p-values of < 10 -2 ) of which are pictured in Figure 5 , and expression profiles of two are displayed in Figure 6 . To assess the biological significance of these results, we use biological models of mechanisms of chromosomal breakage and aneuploidy formation in yeast. Chromosomal amplifications and deletions in yeast are thought to arise through ectopic recombination between homologous sequences, such as Ty transposons, transposon-related long terminal repeats (LTRs), or tRNA sequences (Infante et al., 2003) . Thus, presence of transposons, LTRs, or tRNA sequences near the edges of a predicted aneuploidy region can serve as biological evidence that the region in question truly contains an amplification or deletion. In addition, increased chromosomal breakage may be observed in the conserved Y′ areas at the ends of the yeast chromosomes (Chan and Tye, 1983) . Our analysis reveals that 73% of predictions presented in Figure 5 are significantly (p-value < 0.1) closer to such homologous sequences than expected by chance or are located in the Y′ regions. These predictions likely correspond to novel segmental aneuploidies, while other predictions may represent array artifacts or aneuploidies that arose through an alternative molecular mechanism.
In yeast deletion mutant strains undergoing multiple divisions, an aneuploidy that compensates for or masks the deleted gene's phenotype could confer a selective advantage (Dunham et al., 2002) . For example, growth defects (Saccharomyces Genome Database, 2004) caused by the deletion of anp1 (Figure 6A ), an endoplasmic reticulum (ER) protein with a role in retention of glycosyltransferases in the Golgi (Jungmann and Munro, 1998) , may be alleviated by the amplification of the region on chromosome II that includes SFT2, a gene involved in ER-Golgi transport (Conchon et al., 1999) . The hdf1 deletion mutant also exhibits a compensatory mechanism. Hdf1 protein functions as a heterodimer with the Ku protein in maintaining normal telomere length and structure, but cells can maintain telomeres in the absence of telomerase through a recombination-dependent "survivor" pathway that replicates Y' regions of chromosomes (Lendvay et al., 1996) . Indeed, we identify amplifications in the Y' region of chromosomes II, VI, and XII in this hdf1∆/hdf1∆ strain.
Identification of aneuploidies in breast cancer gene expression and array CGH data
Genomic instability is thought to play a major role in oncogenesis, and breast tumors specifically are known to harbor multiple aneuploidies (Gollin, 2004; Pollack et al., 2002) . Using ChARM, we analyzed array CGH (Pollack et al., 2002) data for 44 breast tumors and the corresponding gene expression studies for 37 of these sample (Sorlie et al., 2003) . Our method identifies the known "hot spots" of amplifications and deletions in breast cancer (Hyman et al., 2002; Pollack et al., 2002) , including multiple cases of deletions on 13q that include tumor suppressor protein Rb1 and on 17p that span tumor suppressor protein Tp53. Deletion of either Rb1 or Tp53 is known to cause chromosomal instability, and we do identify multiple additional aneuploidies in tumors with predicted Rb1 or Tp53 deletion (Lentini et al., 2002) . We also identify a known 17q amplification that includes proto-oncogene ERBB2/HER2 (Menard et al., 2000) .
One advantage of our method is the ability to make predictions based independently on array CGH or gene expression data. Overlaps in these independent predictions can be used to focus on potentially functionally relevant segmental aneuploidies. The two most striking overlap regions both include immune system proteins: genes that encode class II major histocompatability complex proteins (MHCII) on chromosome 6, and immunglobulin heavy chain genes on chromosome 14 (Figure 7) . It is surprising to find such expression levels of these immune proteins in the tumor samples. One concern is that the data reflect the presence of a lymphocytic infiltrate in tumor tissue, however in such a case one would not expect correlated amplification data. Immune system effects on tumor progression are relatively poorly understood; a key question is why some tumors are recognized and destroyed by the immune system while others successfully proliferate.
Immunoglobulins, also known as antibodies, are secretable proteins produced by mature B lymphocytes. These molecules play an essential part in the adaptive immune system by binding and neutralizing foreign particles. As immunoglobulin gene expression typically occurs only in B lymphocytes after directed germline rearrangement, immunoglobulin heavy chain overexpression and amplification of the corresponding region is potentially an important finding, but requires further investigation into the functional status of the transcripts. MHCII is another key component of adaptive immune response -it is a membrane protein whose primary role is the presentation of protein fragments for immune recognition. However, MHCII presentation of foreign proteins activates a response optimally in the presence of other costimulatory molecules, and MHCII overexpression outside of this immune context may lead to immune tolerance, a condition when tumors do not activate immune response (Hardwick, 1998; Hendrickson et al., 2002) . One theory is that malignant tumors may induce tolerance with out-of-context immune stimuli, thereby evading immune response, which allows them to grow and proliferate (Mapara and Sykes, 2004) . No definitive evidence for this theory exists, but these effects have been observed in model systems Byrne and Halliday, 2003) and MHCII overexpression has been associated with poor prognosis in melanomas (Brocker et al., 1985) . Experimental verification of our findings may provide novel evidence of induction of immune tolerance in tumors.
CONCLUSIONS
We have demonstrated that segmental aneuploidies can be identified based on array CGH or gene expression microarray data and have presented a robust statistical method that can accurately locate aneuploidies in biological data. Evaluations on synthetic and biological data show that our method is robust to experimental noise and aneuploidy size and thus is appropriate for general and automated application to microarray data sets. ChARM allows routine screening of gene expression data for aneuploidies and is sensitive enough to detect small statistically significant signal biases in mixed populations of cells. It is important to note that gene expression does not always reflect copy number and, furthermore, algorithms based on gene expression data alone cannot discriminate between spatial expression biases that arise from DNA abnormalities and biases that are the result of spatial coregulation or array artifacts. Our method can identify spatial expression biases due to either aneuploidies or technology artifacts and thus can be used as a general screening tool for gene expression microarray data. In cases when ChARM is used to screen for aneuploidies only, gene expression microarray data should be normalized for special artifacts prior to applying ChARM (Yang et al., 2002) . Applying ChARM to biological data, we have identified multiple previously unknown aneuploidies in public yeast gene expression data, several of which are supported by biological evidence, and potential amplification and overexpression of immune genes in breast cancer. These predictions should be further evaluated through targeted laboratory investigation.
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Array CGH Expression (Table 1) . P-value cutoffs were set at 10 -3 and 10 -2 for the sign and mean permutation tests respectively, and the tests were combined as previously described. The detection scheme with the combined mean and sign window significance test identifies most windows (>90%) with high accuracy in placement of edge coordinates (error < 0.1%) and is robust to high levels of spot, test, and reference noise (substantially higher than noise levels common in biological data shown in Table 1 ). 
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